ABSTRACT
Excitatory synaptic transmission is modulated by inhibitory neurotransmitters and neuromodulators. We found that the synaptic transmission of somatic sensory afferents can be rapidly regulated by a presynaptically secreted protein, follistatin-like 1 (FSTL1), which serves as a direct activator of Na(+),K(+)-ATPase (NKA). The FSTL1 protein is highly expressed in small-diameter neurons of the dorsal root ganglion (DRG). It is transported to axon terminals via small translucent vesicles and secreted in both spontaneous and depolarization-induced manners. Biochemical assays showed that FSTL1 binds to the α1 subunit of NKA and elevates NKA activity. Extracellular FSTL1 induced membrane hyperpolarization in cultured cells and inhibited afferent synaptic transmission in spinal cord slices by activating NKA. Genetic deletion of FSTL1 in small DRG neurons of mice resulted in enhanced afferent synaptic transmission and sensory hypersensitivity, which could be reduced by intrathecally applied FSTL1 protein. Thus, FSTL1-dependent activation of NKA regulates the threshold of somatic sensation.
Subject(s)
Follistatin-Related Proteins/metabolism , Sensory Receptor Cells/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Synaptic Transmission/physiology , Analysis of Variance , Animals , Blotting, Northern , Blotting, Western , COS Cells , Cells, Cultured , Chlorocebus aethiops , Follistatin-Related Proteins/genetics , Ganglia, Spinal/cytology , Ganglia, Spinal/metabolism , Immunohistochemistry , Mice , Mice, Knockout , Patch-Clamp Techniques , Presynaptic Terminals/metabolism , RatsABSTRACT
B-type natriuretic peptide (BNP) has been known to be secreted from cardiac myocytes and activate its receptor, natriuretic peptide receptor-A (NPR-A), to reduce ventricular fibrosis. However, the function of BNP/NPR-A pathway in the somatic sensory system has been unknown. In the present study, we report a novel function of BNP in pain modulation. Using microarray and immunoblot analyses, we found that BNP and NPR-A were expressed in the dorsal root ganglion (DRG) of rats and upregulated after intraplantar injection of complete Freund's adjuvant (CFA). Immunohistochemistry showed that BNP was expressed in calcitonin gene-related peptide (CGRP)-containing small neurons and IB4 (isolectin B4)-positive neurons, whereas NPR-A was present in CGRP-containing neurons. Application of BNP reduced the firing frequency of small DRG neurons in the presence of glutamate through opening large-conductance Ca2+-activated K+ channels (BKCa channels). Furthermore, intrathecal injection of BNP yielded inhibitory effects on formalin-induced flinching behavior and CFA-induced thermal hyperalgesia in rats. Blockade of BNP signaling by BNP antibodies or cGMP-dependent protein kinase (PKG) inhibitor KT5823 [(9S,10R,12R)-2,3,9,10,11,12-hexahydro-10-methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester] impaired the recovery from CFA-induced thermal hyperalgesia. Thus, BNP negatively regulates nociceptive transmission through presynaptic receptor NPR-A, and activation of the BNP/NPR-A/PKG/BKCa channel pathway in nociceptive afferent neurons could be a potential strategy for inflammatory pain therapy.
Subject(s)
Gene Expression Regulation/physiology , Natriuretic Peptide, Brain/metabolism , Pain/metabolism , Sensory Receptor Cells/metabolism , Signal Transduction/physiology , Analysis of Variance , Animals , Antibodies/pharmacology , Antibodies/therapeutic use , Biophysical Phenomena/drug effects , Biophysical Phenomena/physiology , Calcitonin Gene-Related Peptide/metabolism , Carbazoles/pharmacology , Carbazoles/therapeutic use , Disease Models, Animal , Dose-Response Relationship, Drug , Double-Blind Method , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Excitatory Postsynaptic Potentials/drug effects , Freund's Adjuvant , Ganglia, Spinal/pathology , Gene Expression Regulation/drug effects , Glutamic Acid/pharmacology , Hyperalgesia/complications , Hyperalgesia/drug therapy , Inflammation/chemically induced , Inflammation/complications , Lectins/metabolism , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Natriuretic Peptide, Brain/immunology , Pain/drug therapy , Pain/etiology , Pain Measurement/methods , Patch-Clamp Techniques/methods , Peptides/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Atrial Natriuretic Factor/metabolism , Sensory Receptor Cells/drug effects , Signal Transduction/drug effects , Time FactorsABSTRACT
Pancreatitis-associated protein (PAP)-I and -II, lectin-related secretory proteins, are members of the regenerating gene (Reg) family. Although expression of PAP-I was found in the dorsal root ganglion (DRG) neurons following peripheral nerve injury and cystitis, whether PAP-II could be expressed in DRG neurons in chronic pain models remains unclear. The present study shows an inflammation- and nerve injury-triggered expression of PAP-II in rat DRG neurons. In situ hybridization showed that only a few DRG neurons normally contained PAP-I and -II mRNAs. After peripheral inflammation, PAP-I and -II mRNAs were present in over half of small DRG neurons. Such an elevated expression of PAP-I and -II reached the peak level on the second day. Immunostaining showed that the expression of PAP-II was mostly increased in the isolectin B4-positive subset of small DRG neurons after inflammation. Furthermore, the expression of PAP-II was also induced in DRG neurons after peripheral nerve injury. Interestingly, PAP-II expression was shifted from small neurons on day 2 to large DRG neurons that expressed neuropeptide Y during the later post-injury days. These results suggest that PAP-II may play potential roles in the modulation of spinal sensory pathways in pathological pain states.
